APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell and Gene Therapy Cold Chain Logistics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cell and Gene Therapy Cold Chain Logistics Market Analysis and Forecast 2026-2032

4 March 2026196 pages

Choose your research edition.

Industry ResearchCell and Gene Therapy Cold Chain Logistics Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell and Gene Therapy Cold Chain Logistics Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Cell and Gene Therapy Cold Chain Logistics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell and Gene Therapy Cold Chain Logistics Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell and Gene Therapy Cold Chain Logistics Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Cell and Gene Therapy Cold Chain Logistics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cell and Gene Therapy Cold Chain Logistics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cell and Gene Therapy Cold Chain Logistics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cell and Gene Therapy Cold Chain Logistics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cell and Gene Therapy Cold Chain Logistics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cell and Gene Therapy Cold Chain Logistics include AmerisourceBergen Corporation, Arvato Supply Chain Solutions SE, Be The Match BioTherapies, BioLife Solutions, Cardinal Health, Catalent, Cryoport, BioStor Sytems and Marken, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cell and Gene Therapy Cold Chain Logistics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cell and Gene Therapy Cold Chain Logistics, also provides the revenue of main regions and countries. Of the upcoming market potential for Cell and Gene Therapy Cold Chain Logistics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cell and Gene Therapy Cold Chain Logistics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cell and Gene Therapy Cold Chain Logistics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cell and Gene Therapy Cold Chain Logistics revenue, projected growth trends, production technology, application and end-user industry.

Cell and Gene Therapy Cold Chain Logistics Segment by Company

AmerisourceBergen Corporation

Arvato Supply Chain Solutions SE

Be The Match BioTherapies

BioLife Solutions

Cardinal Health

Catalent

Cryoport

BioStor Sytems

Marken

Polar Express Transportation

Thermo Fisher Scientific

Yourway Biopharma Services Company

Cell and Gene Therapy Cold Chain Logistics Segment by Type

Air Freight

Ground Transportation

Water Transport

Cell and Gene Therapy Cold Chain Logistics Segment by Application

Biopharmaceutical & Biotechnology Companies

Academic & Research Institutes

Others

Cell and Gene Therapy Cold Chain Logistics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell and Gene Therapy Cold Chain Logistics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell and Gene Therapy Cold Chain Logistics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell and Gene Therapy Cold Chain Logistics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cell and Gene Therapy Cold Chain Logistics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cell and Gene Therapy Cold Chain Logistics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell and Gene Therapy Cold Chain Logistics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell and Gene Therapy Cold Chain Logistics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Air Freight Major Player Table 3. Ground Transportation Major Player Table 4. Water Transport Major Player Table 5. Global Cell and Gene Therapy Cold Chain Logistics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Biopharmaceutical & Biotechnology Companies Major Player Table 7. Academic & Research Institutes Major Player Table 8. Others Major Player Table 9. Cell and Gene Therapy Cold Chain Logistics Industry Trends Table 10. Cell and Gene Therapy Cold Chain Logistics Industry Drivers Table 11. Cell and Gene Therapy Cold Chain Logistics Industry Opportunities and Challenges Table 12. Cell and Gene Therapy Cold Chain Logistics Industry Restraints Table 13. Global Cell and Gene Therapy Cold Chain Logistics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Cell and Gene Therapy Cold Chain Logistics Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Cell and Gene Therapy Cold Chain Logistics Market Share by Region (2021-2026) Table 16. Global Cell and Gene Therapy Cold Chain Logistics Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Cell and Gene Therapy Cold Chain Logistics Market Share by Region (2027-2032) Table 18. Global Cell and Gene Therapy Cold Chain Logistics Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Players (2021-2026) Table 20. Global Cell and Gene Therapy Cold Chain Logistics Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Cell and Gene Therapy Cold Chain Logistics Key Players Headquarters & Area Served Table 22. Global Cell and Gene Therapy Cold Chain Logistics Players, Product Type & Application Table 23. Global Cell and Gene Therapy Cold Chain Logistics Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Cell and Gene Therapy Cold Chain Logistics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Cell and Gene Therapy Cold Chain Logistics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Type (2021-2026) Table 30. Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Type (2027-2032) Table 31. Global Cell and Gene Therapy Cold Chain Logistics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Application (2021-2026) Table 35. Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Application (2027-2032) Table 36. AmerisourceBergen Corporation Company Information Table 37. AmerisourceBergen Corporation Business Overview Table 38. AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 40. AmerisourceBergen Corporation Recent Development Table 41. Arvato Supply Chain Solutions SE Company Information Table 42. Arvato Supply Chain Solutions SE Business Overview Table 43. Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 45. Arvato Supply Chain Solutions SE Recent Development Table 46. Be The Match BioTherapies Company Information Table 47. Be The Match BioTherapies Business Overview Table 48. Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 50. Be The Match BioTherapies Recent Development Table 51. BioLife Solutions Company Information Table 52. BioLife Solutions Business Overview Table 53. BioLife Solutions Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. BioLife Solutions Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 55. BioLife Solutions Recent Development Table 56. Cardinal Health Company Information Table 57. Cardinal Health Business Overview Table 58. Cardinal Health Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Cardinal Health Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 60. Cardinal Health Recent Development Table 61. Catalent Company Information Table 62. Catalent Business Overview Table 63. Catalent Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Catalent Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 65. Catalent Recent Development Table 66. Cryoport Company Information Table 67. Cryoport Business Overview Table 68. Cryoport Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Cryoport Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 70. Cryoport Recent Development Table 71. BioStor Sytems Company Information Table 72. BioStor Sytems Business Overview Table 73. BioStor Sytems Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. BioStor Sytems Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 75. BioStor Sytems Recent Development Table 76. Marken Company Information Table 77. Marken Business Overview Table 78. Marken Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Marken Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 80. Marken Recent Development Table 81. Polar Express Transportation Company Information Table 82. Polar Express Transportation Business Overview Table 83. Polar Express Transportation Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Polar Express Transportation Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 85. Polar Express Transportation Recent Development Table 86. Thermo Fisher Scientific Company Information Table 87. Thermo Fisher Scientific Business Overview Table 88. Thermo Fisher Scientific Cell and Gene Therapy Cold Chain Logistics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Thermo Fisher Scientific Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 90. Thermo Fisher Scientific Recent Development Table 91. Yourway Biopharma Services Company Company Information Table 92. Yourway Biopharma Services Company Business Overview Table 93. Yourway Biopharma Services Company Cell and Gene Therapy Cold Chain Logistics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Yourway Biopharma Services Company Cell and Gene Therapy Cold Chain Logistics Product Portfolio Table 95. Yourway Biopharma Services Company Recent Development Table 96. North America Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Cell and Gene Therapy Cold Chain Logistics Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Cell and Gene Therapy Cold Chain Logistics Revenue by Country (US$ Million) & (2027-2032) Table 110. China Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021-2026) & (US$ Million) Table 111. China Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2027-2032) & (US$ Million) Table 112. China Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021-2026) & (US$ Million) Table 113. China Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Cell and Gene Therapy Cold Chain Logistics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Cell and Gene Therapy Cold Chain Logistics Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Cell and Gene Therapy Cold Chain Logistics Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Cell and Gene Therapy Cold Chain Logistics Image Figure 2. Global Cell and Gene Therapy Cold Chain Logistics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell and Gene Therapy Cold Chain Logistics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Air Freight Image Figure 5. Ground Transportation Image Figure 6. Water Transport Image Figure 7. Global Cell and Gene Therapy Cold Chain Logistics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Cell and Gene Therapy Cold Chain Logistics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Biopharmaceutical & Biotechnology Companies Image Figure 10. Academic & Research Institutes Image Figure 11. Others Image Figure 12. Global Cell and Gene Therapy Cold Chain Logistics Market Size (US$ Million) & (2021-2032) Figure 13. Global Cell and Gene Therapy Cold Chain Logistics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Cell and Gene Therapy Cold Chain Logistics Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Cell and Gene Therapy Cold Chain Logistics Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Type (2021-2032) Figure 20. Global Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Application (2021-2032) Figure 23. North America Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Cell and Gene Therapy Cold Chain Logistics Revenue Share by Type (2021-2032) Figure 25. North America Cell and Gene Therapy Cold Chain Logistics Revenue Share by Application (2021-2032) Figure 26. North America Cell and Gene Therapy Cold Chain Logistics Revenue Share by Country (2021-2032) Figure 27. United States Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Cell and Gene Therapy Cold Chain Logistics Revenue Share by Type (2021-2032) Figure 32. Europe Cell and Gene Therapy Cold Chain Logistics Revenue Share by Application (2021-2032) Figure 33. Europe Cell and Gene Therapy Cold Chain Logistics Revenue Share by Country (2021-2032) Figure 34. Germany Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Cell and Gene Therapy Cold Chain Logistics Revenue Share by Type (2021-2032) Figure 44. China Cell and Gene Therapy Cold Chain Logistics Revenue Share by Application (2021-2032) Figure 45. Asia Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Cell and Gene Therapy Cold Chain Logistics Revenue Share by Type (2021-2032) Figure 47. Asia Cell and Gene Therapy Cold Chain Logistics Revenue Share by Application (2021-2032) Figure 48. Asia Cell and Gene Therapy Cold Chain Logistics Revenue Share by Region (2021-2032) Figure 49. Japan Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue Share by Type (2021-2032) Figure 57. SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue Share by Application (2021-2032) Figure 58. SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue Share by Country (2021-2032) Figure 59. Brazil Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Cell and Gene Therapy Cold Chain Logistics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Air Freight
  • Ground Transportation
  • Water Transport
Applications
  • Biopharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others
Companies covered
  • AmerisourceBergen Corporation
  • Arvato Supply Chain Solutions SE
  • Be The Match BioTherapies
  • BioLife Solutions
  • Cardinal Health
  • Catalent
  • Cryoport
  • BioStor Sytems
  • Marken
  • Polar Express Transportation
  • Thermo Fisher Scientific
  • Yourway Biopharma Services Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cell and Gene Therapy Cold Chain Logistics Market by Type
  3. 1.2.1 Global Cell and Gene Therapy Cold Chain Logistics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Air Freight
  5. 1.2.3 Ground Transportation
  6. 1.2.4 Water Transport
  7. 1.3 Cell and Gene Therapy Cold Chain Logistics Market by Application
  8. 1.3.1 Global Cell and Gene Therapy Cold Chain Logistics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Biopharmaceutical & Biotechnology Companies
  10. 1.3.3 Academic & Research Institutes
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Cell and Gene Therapy Cold Chain Logistics Market Dynamics
  1. 2.1 Cell and Gene Therapy Cold Chain Logistics Industry Trends
  2. 2.2 Cell and Gene Therapy Cold Chain Logistics Industry Drivers
  3. 2.3 Cell and Gene Therapy Cold Chain Logistics Industry Opportunities and Challenges
  4. 2.4 Cell and Gene Therapy Cold Chain Logistics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cell and Gene Therapy Cold Chain Logistics Market Perspective (2021-2032)
  2. 3.2 Global Cell and Gene Therapy Cold Chain Logistics Growth Trends by Region
  3. 3.2.1 Global Cell and Gene Therapy Cold Chain Logistics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cell and Gene Therapy Cold Chain Logistics Market Size by Region (2021-2026)
  5. 3.2.3 Global Cell and Gene Therapy Cold Chain Logistics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cell and Gene Therapy Cold Chain Logistics Revenue by Players
  2. 4.1.1 Global Cell and Gene Therapy Cold Chain Logistics Revenue by Players (2021-2026)
  3. 4.1.2 Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cell and Gene Therapy Cold Chain Logistics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cell and Gene Therapy Cold Chain Logistics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cell and Gene Therapy Cold Chain Logistics Key Players Headquarters & Area Served
  7. 4.4 Global Cell and Gene Therapy Cold Chain Logistics Players, Product Type & Application
  8. 4.5 Global Cell and Gene Therapy Cold Chain Logistics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cell and Gene Therapy Cold Chain Logistics Market CR5 and HHI
  11. 4.6.3 2025 Cell and Gene Therapy Cold Chain Logistics Tier 1, Tier 2, and Tier 3
5 Cell and Gene Therapy Cold Chain Logistics Market Size by Type
  1. 5.1 Global Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021-2032)
  3. 5.3 Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Type (2021-2032)
6 Cell and Gene Therapy Cold Chain Logistics Market Size by Application
  1. 6.1 Global Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021-2032)
  3. 6.3 Global Cell and Gene Therapy Cold Chain Logistics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AmerisourceBergen Corporation
  2. 7.1.1 AmerisourceBergen Corporation Company Information
  3. 7.1.2 AmerisourceBergen Corporation Business Overview
  4. 7.1.3 AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AmerisourceBergen Corporation Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  6. 7.1.5 AmerisourceBergen Corporation Recent Developments
  7. 7.2 Arvato Supply Chain Solutions SE
  8. 7.2.1 Arvato Supply Chain Solutions SE Company Information
  9. 7.2.2 Arvato Supply Chain Solutions SE Business Overview
  10. 7.2.3 Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Arvato Supply Chain Solutions SE Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  12. 7.2.5 Arvato Supply Chain Solutions SE Recent Developments
  13. 7.3 Be The Match BioTherapies
  14. 7.3.1 Be The Match BioTherapies Company Information
  15. 7.3.2 Be The Match BioTherapies Business Overview
  16. 7.3.3 Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Be The Match BioTherapies Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  18. 7.3.5 Be The Match BioTherapies Recent Developments
  19. 7.4 BioLife Solutions
  20. 7.4.1 BioLife Solutions Company Information
  21. 7.4.2 BioLife Solutions Business Overview
  22. 7.4.3 BioLife Solutions Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 BioLife Solutions Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  24. 7.4.5 BioLife Solutions Recent Developments
  25. 7.5 Cardinal Health
  26. 7.5.1 Cardinal Health Company Information
  27. 7.5.2 Cardinal Health Business Overview
  28. 7.5.3 Cardinal Health Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Cardinal Health Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  30. 7.5.5 Cardinal Health Recent Developments
  31. 7.6 Catalent
  32. 7.6.1 Catalent Company Information
  33. 7.6.2 Catalent Business Overview
  34. 7.6.3 Catalent Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Catalent Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  36. 7.6.5 Catalent Recent Developments
  37. 7.7 Cryoport
  38. 7.7.1 Cryoport Company Information
  39. 7.7.2 Cryoport Business Overview
  40. 7.7.3 Cryoport Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Cryoport Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  42. 7.7.5 Cryoport Recent Developments
  43. 7.8 BioStor Sytems
  44. 7.8.1 BioStor Sytems Company Information
  45. 7.8.2 BioStor Sytems Business Overview
  46. 7.8.3 BioStor Sytems Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 BioStor Sytems Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  48. 7.8.5 BioStor Sytems Recent Developments
  49. 7.9 Marken
  50. 7.9.1 Marken Company Information
  51. 7.9.2 Marken Business Overview
  52. 7.9.3 Marken Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Marken Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  54. 7.9.5 Marken Recent Developments
  55. 7.10 Polar Express Transportation
  56. 7.10.1 Polar Express Transportation Company Information
  57. 7.10.2 Polar Express Transportation Business Overview
  58. 7.10.3 Polar Express Transportation Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Polar Express Transportation Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  60. 7.10.5 Polar Express Transportation Recent Developments
  61. 7.11 Thermo Fisher Scientific
  62. 7.11.1 Thermo Fisher Scientific Company Information
  63. 7.11.2 Thermo Fisher Scientific Business Overview
  64. 7.11.3 Thermo Fisher Scientific Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Thermo Fisher Scientific Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  66. 7.11.5 Thermo Fisher Scientific Recent Developments
  67. 7.12 Yourway Biopharma Services Company
  68. 7.12.1 Yourway Biopharma Services Company Company Information
  69. 7.12.2 Yourway Biopharma Services Company Business Overview
  70. 7.12.3 Yourway Biopharma Services Company Cell and Gene Therapy Cold Chain Logistics Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Yourway Biopharma Services Company Cell and Gene Therapy Cold Chain Logistics Product Portfolio
  72. 7.12.5 Yourway Biopharma Services Company Recent Developments
8 North America
  1. 8.1 North America Cell and Gene Therapy Cold Chain Logistics Revenue (2021-2032)
  2. 8.2 North America Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021-2032)
  3. 8.2.1 North America Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021-2026)
  4. 8.2.2 North America Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2027-2032)
  5. 8.3 North America Cell and Gene Therapy Cold Chain Logistics Revenue Share by Type (2021-2032)
  6. 8.4 North America Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021-2032)
  7. 8.4.1 North America Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021-2026)
  8. 8.4.2 North America Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2027-2032)
  9. 8.5 North America Cell and Gene Therapy Cold Chain Logistics Revenue Share by Application (2021-2032)
  10. 8.6 North America Cell and Gene Therapy Cold Chain Logistics Revenue by Country
  11. 8.6.1 North America Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2021-2026)
  13. 8.6.3 North America Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cell and Gene Therapy Cold Chain Logistics Revenue (2021-2032)
  2. 9.2 Europe Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2027-2032)
  5. 9.3 Europe Cell and Gene Therapy Cold Chain Logistics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2027-2032)
  9. 9.5 Europe Cell and Gene Therapy Cold Chain Logistics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cell and Gene Therapy Cold Chain Logistics Revenue by Country
  11. 9.6.1 Europe Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cell and Gene Therapy Cold Chain Logistics Revenue (2021-2032)
  2. 10.2 China Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021-2032)
  3. 10.2.1 China Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021-2026)
  4. 10.2.2 China Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2027-2032)
  5. 10.3 China Cell and Gene Therapy Cold Chain Logistics Revenue Share by Type (2021-2032)
  6. 10.4 China Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021-2032)
  7. 10.4.1 China Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021-2026)
  8. 10.4.2 China Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2027-2032)
  9. 10.5 China Cell and Gene Therapy Cold Chain Logistics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cell and Gene Therapy Cold Chain Logistics Revenue (2021-2032)
  2. 11.2 Asia Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2027-2032)
  5. 11.3 Asia Cell and Gene Therapy Cold Chain Logistics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2027-2032)
  9. 11.5 Asia Cell and Gene Therapy Cold Chain Logistics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cell and Gene Therapy Cold Chain Logistics Revenue by Country
  11. 11.6.1 Asia Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue (2021-2032)
  2. 12.2 SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue by Country
  11. 12.6.1 SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cell and Gene Therapy Cold Chain Logistics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst